Barinthus Biotherapeutics PLC BRNS

Full chart Compare
Set alert

Price alert · BRNS

All alert types
0.74 USD -0.02 (-2.49%)

At closeSep 8, 2026, 4:00 PM EDT

0.74 0.00 -0.57%

After hours · Sep 8, 4:00 PM ET

0.6421 Day range 0.7629
0.512 52-week range 1.38
YTD
+5.73%
1 year
-19.82%

Financial health

Altman Z-Score

-5.68 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2019: -0.0×FY 2020: -6.3×FY 2021: -8.1×FY 2022: 16.8×FY 2023: -1.9×FY 2024: -0.8×FY 2025: -0.4×
FY 2019 5y median -0.8× FY 2025
P/S 0.0×
FY 2019: 16.1×FY 2020: 23.1×FY 2021: 1542×FY 2022: 2.0×FY 2023: 177×FY 2024: 3.2×FY 2025: 0.0×
FY 2019 5y median 3.2× FY 2025
P/B 0.4×
FY 2019: -4.9×FY 2020: -31.5×FY 2021: 1.6×FY 2022: 0.4×FY 2023: 0.8×FY 2024: 0.4×FY 2025: 0.4×
FY 2019 5y median 0.4× FY 2025
P/FCF -0.6×
FY 2019: -5.8×FY 2020: -9.8×FY 2021: -12.2×FY 2022: -4.3×FY 2023: -2.5×FY 2024: -1.6×FY 2025: -0.6×
FY 2019 5y median -2.5× FY 2025
EV/EBITDA 0.5×
FY 2019: -4.5×FY 2020: -6.9×FY 2021: -4.3×FY 2022: -18.9×FY 2023: -0.2×FY 2024: 0.9×FY 2025: 0.5×
FY 2019 5y median -0.2× FY 2025
EV/Sales 0.0×
FY 2019: 14.7×FY 2020: 23.8×FY 2021: 770×FY 2022: -2.2×FY 2023: 15.6×FY 2024: -3.4×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -169.2%
FY 2019: -17.1%FY 2020: -10.2%FY 2021: -8.2%FY 2022: -23.5%FY 2023: -39.8%FY 2024: -62.7%FY 2025: -169.2%
FY 2019 5y median -39.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: -336.0%FY 2020: -198.4%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2019: -374.9%FY 2020: -415.8%FY 2021: -16873.5%FY 2022: -9.0%FY 2023: -10463.1%FY 2024: -454.1%FY 2025: 0.0%
FY 2019 5y median -454.1% FY 2025
Net Margin 0.0%
FY 2019: -302.8%FY 2020: -367.3%FY 2021: -18979.5%FY 2022: 11.9%FY 2023: -9145.5%FY 2024: -408.0%FY 2025: 0.0%
FY 2019 5y median -408.0% FY 2025
ROE -89.7%
FY 2019: 92.4%FY 2020: 500.5%FY 2021: -20.2%FY 2022: 2.2%FY 2023: -39.3%FY 2024: -47.0%FY 2025: -89.7%
FY 2019 5y median -39.3% FY 2025
ROIC -58.2%
FY 2019: -190.6%FY 2020: -46.4%FY 2021: -16.7%FY 2022: -1.6%FY 2023: -39.5%FY 2024: -46.3%FY 2025: -58.2%
FY 2019 5y median -39.5% FY 2025
ROA -67.8%
FY 2019: -108.9%FY 2020: -34.9%FY 2021: -18.1%FY 2022: 2.0%FY 2023: -34.2%FY 2024: -38.1%FY 2025: -67.8%
FY 2019 5y median -34.2% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2019: 0.0%FY 2020: -29.6%FY 2021: -94.4%FY 2022: 16580.2%FY 2023: -98.2%FY 2024: 1766.5%FY 2025: -100.0%
FY 2019 FY 2025
Operating Income 20.3%
FY 2019: 0.0%FY 2020: 21.9%FY 2021: -125.6%FY 2022: 91.1%FY 2023: -1976.6%FY 2024: 19.0%FY 2025: 20.3%
FY 2019 FY 2025
EPS (diluted) -5.8%
FY 2019: 0.0%FY 2020: 99.5%FY 2021: 38.8%FY 2022: 110.2%FY 2023: -1464.3%FY 2024: 18.8%FY 2025: -5.8%
FY 2019 FY 2025
Free Cash Flow -61.0%
FY 2019: 0.0%FY 2020: 40.1%FY 2021: -197.9%FY 2022: 39.0%FY 2023: -173.9%FY 2024: 47.0%FY 2025: -61.0%
FY 2019 FY 2025

Financial Health

Current Ratio 7.8×
FY 2019: 2.8×FY 2020: 6.3×FY 2021: 20.3×FY 2022: 17.4×FY 2023: 12.5×FY 2024: 8.0×FY 2025: 7.8×
FY 2019 5y median 12.5× FY 2025
Quick Ratio 7.8×
FY 2019: 2.8×FY 2020: 6.3×FY 2021: 20.3×FY 2022: 17.4×FY 2023: 12.5×FY 2024: 8.0×FY 2025: 7.8×
FY 2019 5y median 12.5× FY 2025
Debt / Equity 0.2×
FY 2019: -0.1×FY 2020: -13.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 0.9×
FY 2019: 0.4×FY 2020: -0.2×FY 2021: 4.3×FY 2022: -35.7×FY 2023: 1.8×FY 2024: 1.8×FY 2025: 0.9×
FY 2019 5y median 1.8× FY 2025
Interest Coverage -1060×
FY 2019: -193×FY 2020: -5.6×FY 2021: -16.9×FY 2022: -213×FY 2023: -2997×FY 2024: -1282×FY 2025: -1060×
FY 2019 5y median -1060× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31